Skip to main content
Top
Published in: BMC Health Services Research 1/2011

Open Access 01-12-2011 | Debate

The social value of a QALY: raising the bar or barring the raise?

Authors: Cam Donaldson, Rachel Baker, Helen Mason, Michael Jones-Lee, Emily Lancsar, John Wildman, Ian Bateman, Graham Loomes, Angela Robinson, Robert Sugden, Jose Luis Pinto Prades, Mandy Ryan, Phil Shackley, Richard Smith

Published in: BMC Health Services Research | Issue 1/2011

Login to get access

Abstract

Background

Since the inception of the National Institute for Health and Clinical Excellence (NICE) in England, there have been questions about the empirical basis for the cost-per-QALY threshold used by NICE and whether QALYs gained by different beneficiaries of health care should be weighted equally. The Social Value of a QALY (SVQ) project, reported in this paper, was commissioned to address these two questions. The results of SVQ were released during a time of considerable debate about the NICE threshold, and authors with differing perspectives have drawn on the SVQ results to support their cases. As these discussions continue, and given the selective use of results by those involved, it is important, therefore, not only to present a summary overview of SVQ, but also for those who conducted the research to contribute to the debate as to its implications for NICE.

Discussion

The issue of the threshold was addressed in two ways: first, by combining, via a set of models, the current UK Value of a Prevented Fatality (used in transport policy) with data on fatality age, life expectancy and age-related quality of life; and, second, via a survey designed to test the feasibility of combining respondents' answers to willingness to pay and health state utility questions to arrive at values of a QALY. Modelling resulted in values of £10,000-£70,000 per QALY. Via survey research, most methods of aggregating the data resulted in values of a QALY of £18,000-£40,000, although others resulted in implausibly high values. An additional survey, addressing the issue of weighting QALYs, used two methods, one indicating that QALYs should not be weighted and the other that greater weight could be given to QALYs gained by some groups.

Summary

Although we conducted only a feasibility study and a modelling exercise, neither present compelling evidence for moving the NICE threshold up or down. Some preliminary evidence would indicate it could be moved up for some types of QALY and down for others. While many members of the public appear to be open to the possibility of using somewhat different QALY weights for different groups of beneficiaries, we do not yet have any secure evidence base for introducing such a system.
Literature
1.
go back to reference Phelps CE, Mushlin AI: On the (near) equivalence of cost-effectiveness and cost-benefit analyses. International Journal of Technology Assessment in Health Care. 1991, 7: 12-21. 10.1017/S0266462300004803.CrossRefPubMed Phelps CE, Mushlin AI: On the (near) equivalence of cost-effectiveness and cost-benefit analyses. International Journal of Technology Assessment in Health Care. 1991, 7: 12-21. 10.1017/S0266462300004803.CrossRefPubMed
2.
go back to reference Hirth RA, Chernew ME, Miller E, Fendrick M, Weissert WG: Willingness to pay for a quality-adjusted life year: in search of a standard. Medical Decision Making. 2000, 20: 332-42. 10.1177/0272989X0002000310.CrossRefPubMed Hirth RA, Chernew ME, Miller E, Fendrick M, Weissert WG: Willingness to pay for a quality-adjusted life year: in search of a standard. Medical Decision Making. 2000, 20: 332-42. 10.1177/0272989X0002000310.CrossRefPubMed
3.
go back to reference Gyrd-Hansen D: Willingness to pay for a QALY. Health Economics. 2003, 12: 1049-60. 10.1002/hec.799.CrossRefPubMed Gyrd-Hansen D: Willingness to pay for a QALY. Health Economics. 2003, 12: 1049-60. 10.1002/hec.799.CrossRefPubMed
4.
go back to reference Byrne MM, O'Malley K, Suarez-Almazor ME: Willingness to pay per quality adjusted life year in a study of knee osteoarthritis. Medical Decision Making. 2005, 25: 655-666. 10.1177/0272989X05282638.CrossRefPubMed Byrne MM, O'Malley K, Suarez-Almazor ME: Willingness to pay per quality adjusted life year in a study of knee osteoarthritis. Medical Decision Making. 2005, 25: 655-666. 10.1177/0272989X05282638.CrossRefPubMed
5.
go back to reference King JT, Tsevat J, Lave J, Roberts MS: Willingness to pay for a quality adjusted life year: implications for societal resource allocation. Medical Decision Making. 2005, 25: 667-677. 10.1177/0272989X05282640.CrossRefPubMed King JT, Tsevat J, Lave J, Roberts MS: Willingness to pay for a quality adjusted life year: implications for societal resource allocation. Medical Decision Making. 2005, 25: 667-677. 10.1177/0272989X05282640.CrossRefPubMed
7.
go back to reference Devlin N, Parkin D: Does NICE have a cost-effectiveness threshold and what other factors influence its decisions?. Health Economics. 2004, 13: 437-452. 10.1002/hec.864.CrossRefPubMed Devlin N, Parkin D: Does NICE have a cost-effectiveness threshold and what other factors influence its decisions?. Health Economics. 2004, 13: 437-452. 10.1002/hec.864.CrossRefPubMed
8.
go back to reference Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ: Using effectiveness and cost-effectiveness to make drug coverage decisions. Journal of the American Medical Association. 2009, 302: 1437-1443. 10.1001/jama.2009.1409.CrossRefPubMed Clement FM, Harris A, Li JJ, Yong K, Lee KM, Manns BJ: Using effectiveness and cost-effectiveness to make drug coverage decisions. Journal of the American Medical Association. 2009, 302: 1437-1443. 10.1001/jama.2009.1409.CrossRefPubMed
9.
go back to reference House of Commons Health Committee: National Institute for Clinical Excellence. Second Report of Session 2001-02. 2002, The Stationary Office House of Commons Health Committee: National Institute for Clinical Excellence. Second Report of Session 2001-02. 2002, The Stationary Office
10.
go back to reference Lakhani N: The Price of life: it was £20,000. Now an NHS agency recalculates. Independent on Sunday. 2008, 18-19. Lakhani N: The Price of life: it was £20,000. Now an NHS agency recalculates. Independent on Sunday. 2008, 18-19.
11.
go back to reference Richards M: Improving access to medicines for NHS patients. 2008, Department of Health, London Richards M: Improving access to medicines for NHS patients. 2008, Department of Health, London
12.
go back to reference West D: Spending pressures spark call for NICE restraints. 2009, Health Service Journal West D: Spending pressures spark call for NICE restraints. 2009, Health Service Journal
13.
go back to reference Towse A: Should NICE's threshold range for the QALY be raised? Yes. BMJ. 2009, 338: 268-269. 10.1136/bmj.b181.CrossRef Towse A: Should NICE's threshold range for the QALY be raised? Yes. BMJ. 2009, 338: 268-269. 10.1136/bmj.b181.CrossRef
14.
go back to reference Raftery J: Should NICE's threshold range for the QALY be raised? No. BMJ. 2009, 338: 268-269. 10.1136/bmj.b268.CrossRef Raftery J: Should NICE's threshold range for the QALY be raised? No. BMJ. 2009, 338: 268-269. 10.1136/bmj.b268.CrossRef
15.
go back to reference Mason H, Jones-Lee MW, Donaldson C: Modelling the monetary value of a QALY: a new approach based on UK data. Health Economics. 2009, 18: 933-950. 10.1002/hec.1416.CrossRefPubMed Mason H, Jones-Lee MW, Donaldson C: Modelling the monetary value of a QALY: a new approach based on UK data. Health Economics. 2009, 18: 933-950. 10.1002/hec.1416.CrossRefPubMed
16.
go back to reference Baker R, Bateman I, Donaldson C, Jones-Lee M, Lancsar E, Loomes G, et al: Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY project. Health Technol Assess. 2010, 14 (27). Baker R, Bateman I, Donaldson C, Jones-Lee M, Lancsar E, Loomes G, et al: Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY project. Health Technol Assess. 2010, 14 (27).
17.
go back to reference Smith R, Porter A: NHS ordered to place more value on life. Daily Telegraph. 2008, 1. Smith R, Porter A: NHS ordered to place more value on life. Daily Telegraph. 2008, 1.
18.
go back to reference Martin S, Rice N, Smith PJ: Does health care spending improve health outcomes? Evidence from English programme budgeting data. Journal of Health Economics. 2008, 27: 826-842. 10.1016/j.jhealeco.2007.12.002.CrossRefPubMed Martin S, Rice N, Smith PJ: Does health care spending improve health outcomes? Evidence from English programme budgeting data. Journal of Health Economics. 2008, 27: 826-842. 10.1016/j.jhealeco.2007.12.002.CrossRefPubMed
19.
go back to reference Appleby J, Devlin N, Parkin D, Chalkidou K, Buxton M: Searching for cost effectiveness thresholds in the NHS. Health Policy. 2009, 9: 239-245. 10.1016/j.healthpol.2008.12.010.CrossRef Appleby J, Devlin N, Parkin D, Chalkidou K, Buxton M: Searching for cost effectiveness thresholds in the NHS. Health Policy. 2009, 9: 239-245. 10.1016/j.healthpol.2008.12.010.CrossRef
20.
go back to reference Department for Transport: Highways Economic Note No 1, 2005. 2007, London Department for Transport: Highways Economic Note No 1, 2005. 2007, London
21.
go back to reference Jones-Lee MW, Loomes G, Philips P: Valuing the prevention of non-fatal road injuries: contingent valuation vs standard gambles. Oxford Economic Papers. 1995, 47: 676-695. Jones-Lee MW, Loomes G, Philips P: Valuing the prevention of non-fatal road injuries: contingent valuation vs standard gambles. Oxford Economic Papers. 1995, 47: 676-695.
22.
go back to reference Donaldson C, Mason H, Shackley P: Contingent valuation in health care. Edited by: Jones A. 2006, The Elgar Companion to Health Economics. Elgar, CheltenhamCrossRef Donaldson C, Mason H, Shackley P: Contingent valuation in health care. Edited by: Jones A. 2006, The Elgar Companion to Health Economics. Elgar, CheltenhamCrossRef
23.
go back to reference Murray CJL, Lopez AD: The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. 1996, Harvard University Press, Cambridge Murray CJL, Lopez AD: The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. 1996, Harvard University Press, Cambridge
24.
go back to reference Nord E: The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy. 1993, 24: 227-238. 10.1016/0168-8510(93)90042-N.CrossRefPubMed Nord E: The trade-off between severity of illness and treatment effect in cost-value analysis of health care. Health Policy. 1993, 24: 227-238. 10.1016/0168-8510(93)90042-N.CrossRefPubMed
25.
go back to reference Nord E: The relevance of health state after treatment in prioritizing between different patients. Journal of Medical Ethics. 1993, 19: 37-42. 10.1136/jme.19.1.37.CrossRefPubMedPubMedCentral Nord E: The relevance of health state after treatment in prioritizing between different patients. Journal of Medical Ethics. 1993, 19: 37-42. 10.1136/jme.19.1.37.CrossRefPubMedPubMedCentral
26.
go back to reference Brouwer W, van Exel J, Baker R, Donaldson C: The new myth: The social value of the QALY. PharmacoEconomics. 2008, 26 (1): 1-4. 10.2165/00019053-200826010-00001.CrossRefPubMed Brouwer W, van Exel J, Baker R, Donaldson C: The new myth: The social value of the QALY. PharmacoEconomics. 2008, 26 (1): 1-4. 10.2165/00019053-200826010-00001.CrossRefPubMed
27.
go back to reference Mason H: Monetary valuation of health outcomes for use in national policy formulation. 2007, PhD thesis, Newcastle University Mason H: Monetary valuation of health outcomes for use in national policy formulation. 2007, PhD thesis, Newcastle University
28.
go back to reference Jones-Lee M, Loomes G, Spackman M: Human Costs of a Nuclear Accident: Final Report. 2007, Health and Safety Executive NERA Economic Consulting Jones-Lee M, Loomes G, Spackman M: Human Costs of a Nuclear Accident: Final Report. 2007, Health and Safety Executive NERA Economic Consulting
29.
go back to reference Mendeloff JM, Kaplan RM: Are large differences in 'lifesaving' costs justified ? A psychometric study of the relative value placed on preventing deaths. Risk Analysis. 1989, 9: 349-363. 10.1111/j.1539-6924.1989.tb01001.x.CrossRefPubMed Mendeloff JM, Kaplan RM: Are large differences in 'lifesaving' costs justified ? A psychometric study of the relative value placed on preventing deaths. Risk Analysis. 1989, 9: 349-363. 10.1111/j.1539-6924.1989.tb01001.x.CrossRefPubMed
30.
go back to reference Dolan P, Green C: Using the person trade-off approach to examine differences between individual and social values. Health Economics. 1996, 7: 307-312. 10.1002/(SICI)1099-1050(199806)7:4<307::AID-HEC345>3.0.CO;2-N.CrossRef Dolan P, Green C: Using the person trade-off approach to examine differences between individual and social values. Health Economics. 1996, 7: 307-312. 10.1002/(SICI)1099-1050(199806)7:4<307::AID-HEC345>3.0.CO;2-N.CrossRef
31.
go back to reference Nord E, Street A, Richardson J, Kuhse H, Singer P: The significance of age and duration of effect in social evaluation of health care. Health Care Analysis. 1996, 4: 103-111.CrossRefPubMed Nord E, Street A, Richardson J, Kuhse H, Singer P: The significance of age and duration of effect in social evaluation of health care. Health Care Analysis. 1996, 4: 103-111.CrossRefPubMed
32.
go back to reference Johansson-Stenman O, Martinsson P: Are some lives more valuable? An ethical preferences approach. Journal of Health Economics. 2008, 27: 739-752. 10.1016/j.jhealeco.2007.10.001.CrossRefPubMed Johansson-Stenman O, Martinsson P: Are some lives more valuable? An ethical preferences approach. Journal of Health Economics. 2008, 27: 739-752. 10.1016/j.jhealeco.2007.10.001.CrossRefPubMed
33.
go back to reference Nord E, Richardson J, et al: Maximising health benefits versus egalitarianism: An Australian survey of health issues. Social Science & Medicine. 1995, 41: 1429-1437.CrossRef Nord E, Richardson J, et al: Maximising health benefits versus egalitarianism: An Australian survey of health issues. Social Science & Medicine. 1995, 41: 1429-1437.CrossRef
34.
go back to reference Nord E: Cost-value Analysis in Health Care. 1999, Cambridge University Press, CambridgeCrossRef Nord E: Cost-value Analysis in Health Care. 1999, Cambridge University Press, CambridgeCrossRef
35.
go back to reference Abellan-Perpinan JM, Pinto-Prades JL: Health state after treatment: a reason for discrimination. Health Economics. 1999, 8: 701-708. 10.1002/(SICI)1099-1050(199912)8:8<701::AID-HEC473>3.0.CO;2-M.CrossRefPubMed Abellan-Perpinan JM, Pinto-Prades JL: Health state after treatment: a reason for discrimination. Health Economics. 1999, 8: 701-708. 10.1002/(SICI)1099-1050(199912)8:8<701::AID-HEC473>3.0.CO;2-M.CrossRefPubMed
36.
go back to reference Ubel P, Richardson J, Pinto Prades JL: Life saving treatments and disabilities: Are all QALYs created equal?. Int J of Techn Assessement in Health Care. 1999, 15: 738-748. Ubel P, Richardson J, Pinto Prades JL: Life saving treatments and disabilities: Are all QALYs created equal?. Int J of Techn Assessement in Health Care. 1999, 15: 738-748.
37.
go back to reference Dolan P, Cookson R: Measuring preferences over the distribution of health benefits. 1998, Mimeo. Centre for Health Economics, University of York Dolan P, Cookson R: Measuring preferences over the distribution of health benefits. 1998, Mimeo. Centre for Health Economics, University of York
38.
39.
go back to reference National Institute for Health and Clinical Excellence: Social Value Judgements: Principles for the Development of NICE Guidance. 2008, NICE, London, 2 National Institute for Health and Clinical Excellence: Social Value Judgements: Principles for the Development of NICE Guidance. 2008, NICE, London, 2
Metadata
Title
The social value of a QALY: raising the bar or barring the raise?
Authors
Cam Donaldson
Rachel Baker
Helen Mason
Michael Jones-Lee
Emily Lancsar
John Wildman
Ian Bateman
Graham Loomes
Angela Robinson
Robert Sugden
Jose Luis Pinto Prades
Mandy Ryan
Phil Shackley
Richard Smith
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2011
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-11-8

Other articles of this Issue 1/2011

BMC Health Services Research 1/2011 Go to the issue